Pfizer Head of Preclinical Outsourcing VP Richard Connell On “Pausing” Anti-Infectives Research In China, And Taking A Long View On Asian Partnerships: An Interview With PharmAsia News (Part 1 of 2)

On the way back to his old job in the U.S., after a stint in Shanghai as head of research Asia, Richard Connell says Pfizer is “pausing” plans for an anti-infectives research unit in China after hitting a few speed bumps.

HYDERABAD, India – En route back home to Groton, Connecticut from Shanghai, Pfizer Inc. Head of Preclinical Outsourcing VP Richard Connell sat down with PharmAsia News last month along the sidelines of the BIO Asia conference in Hyderabad, India, to talk about Pfizer’s research efforts in Asia. Connell had stepped in to take over as Pfizer’s head of research, Asia, following the departure of Steve Yang, a leading light in the China pharma world, who jumped to AstraZeneca PLC to rejoin his old boss Martin Mackay, Pfizer’s former R&D chief and current head of R&D at AZ (Also see "Pfizer Shake Up Continues With Key Exits From Emerging Markets" - Scrip, 10 December, 2010.)

In this interview, Connell shares his experiences in Shanghai and India, where Pfizer has partnered with local companies on preclinical...

More from Focus On Asia

More from Scrip

Quick Listen: Scrip’s Five Must-Know Things

 
• By 

In this week's episode: J&J delivers in Q2 despite Stelara drop; Sarepta cuts jobs as Elevidys slumps; AI is inevitable but needs to be applied appropriately; China’s mid-cap companies thrive; and a look behind Glenmark’s landmark trispecific deal.

Chief Strategist O’Hara On Novavax’s Partnership-Focused Approach

 
• By 

A deal last year with Sanofi relieved Novavax of commercial costs for the COVID-19 vaccine Nuvaxovid, allowing the company to focus on R&D and finding partners for its other vaccines.

Pharma Gets A Compatriot At CDER With Tidmarsh Appointment To Top Spot

 

Drug manufacturers may find comfort in the appointment of former biotech CEO and entrepreneur George Tidmarsh to lead the FDA’s Center for Drug Evaluation and Research.